DOCSLIB.ORG

Investigation of a Transcription Factor Complex and Intrinsically Disordered Proteins

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Investigation of a transcription factor complex and intrinsically disordered proteins Vania Santos Caldas 27, 524 words A thesis submitted in fulfilment of the requirements for the degree of Master of Philosophy Faculty of Science School of Life and Environmental Sciences The University of Sydney February 2018 i Statement of originaliy This is to certify that to the best of my knowledge, the content of this thesis is my own work. This thesis has not been submitted for any degree or other purposes. I certify that the intellectual content of this thesis is the product of my own work and that all the assistance received in preparing this thesis and sources have been acknowledged. Vania Santos Caldas ii Acknowledgments I would like to thank everyone who helped me get through my Master’s degree. Firstly, thank you to my supervisor, Jacqui, for not only taking me on as a student but also always being encouraging and guiding me through this experience. And thank you of course, for all the thesis editing. You’ve helped me learn so much over the last few years. I would like to thank everyone in the Mackay/Matthews/Ataide lab, everyone was always so willing to help and provide advice. I feel very grateful to work in such a supportive environment, with people with such a variety of skills they are willing to share – advice on directions of my experiments, helping with using equipment, or even as simple as showing me where something was stored. Thank you especially to Flyp and Lorna for all the help in the lab. And a huge thank you to Neil for helping me with my cloning woes. Thank you to everyone to helped out with reading my thesis, Lorna, Flyp, Neil and Jason. I am very appreciative of all of your feedback. As well as all the excellent help with science provided from everyone, you also provided an excellent environment. I would not have enjoyed my experience in the lab as much as I did if it wasn’t for the people I got to meet and become friends with. Whether it be by chatting at our benches while doing minipreps, eating cake or commiserating over failed experiments, you all made each day better. I will truly miss working with you all each day. Thank you to all of my family and friends for their constant support. Thank you to my parents, for always encouraging and supporting me, and for putting up with my extreme stress levels. Thank you for taking over the cat parenting duties when I moved out. Thank you to Athina, for always being there to listen to me and support me over a coffee. Thank you to Taylor, for always encouraging me and making me smile. Knowing that I would go home and see you each day, made every day better. And finally, thank you to my partner James. You helped me through all the ups and downs (a lot of downs) of the past two years. I will forever be thankful for all your words of support and encouragement, and helping me stumble towards my future. I wouldn’t be where I am without you. I gratefully acknowledge the support of my scholarship, ‘Postgraduate Scholarship in Assembly of Transcriptional Complexes’. iii Abstract LIM domain binding protein 1 (Ldb1) is a chromatin looping factor that forms part of a transcriptional ‘pentameric complex’. Ldb1 contains two domains that are essential for looping: a self-association domain, and a LIM interaction domain (LID) that binds LIM proteins such as Lmo2, which in turn binds to DNA binding transcription factors, Tal1, E2a and Gata-1. It was proposed that the Gata-1 binding protein FOG1 could bind to the pentameric complex. GFP-tagged FOG1 was shown to bind the complex by multi angle laser light scattering, providing a mechanism by which the intrinsically weak Gata-1/FOG1 interaction is bolstered through binding to other units of the pentameric complex. Little is known about proteins that are distantly related to mammalian Ldb1. Two such proteins, Ldb1 from C. elegans and Adn1 from S. pombe were expressed in bacteria. They had generally poor solubility, but use of a maltose binding protein tag promoted solubility, and different expression systems may enable their further study. Ldb1 was reported to bind the E3 ubiquitin ligase protein, RLIM. No interaction could be detected between these proteins by yeast two-hybrid analysis using truncated or full length proteins. The interaction was detected in mammalian cells using FLAG pull-down experiments, but truncation mutants of these proteins could not be expressed. RLIM has high levels of predicted disorder, which may contribute to its degradation in both cell types. An assay was developed in which dimerization domains could stabilise disordered binding regions. Constructs containing GST, a coiled-coil domain of CtIP, or the leucine zipper of GCN4, were tethered to a test peptide and assayed for binding in yeast two-hybrid assays. The domains from CtIP and/or GCN4 allowed the interaction to be detected. Although the assay could not detect an interaction between RLIM and Ldb1, it shows promise for detecting interactions for disordered proteins, and can be adapted to different expression systems. iv Abbreviations 3-AT 3-amino-1,2,4-triazole 3C Chromosome conformation capture 3C-seq Chromosome conformation capture sequencing AD Activation domain Adn1 Adhesion defective protein 1 Amp Ampicillin AUC Analytical ultracentrifugation BD DNA binding domain bHLH Basic helix loop helix BSA Bovine serum albumin C. elegans Caenorhabditis elegans Cam Chloramphenicol cDNA Complementary DNA CeLdb1 Ldb1 from C. elegans CF/C-finger Carboxy-terminal zinc finger ChIP Chromatin immunoprecipitation CSM Complete supplement mixture CtIP DNA endoculease RBBP8 CV Column volume(s) D. melanogaster Drosophila melanogaster Da Dalton DD Dimerisation domain Deaf1 Deformed epidermal autoregulatory factor DMSO Dimethyl sulfoxide DNA Deoxyribonucleic acid dNTP Deoxynucleotide triphosphate DTT Dithiothreitol E. coli Escherichia coli E2a Transcription factor E2-alpha v E-box Enhancer box EDTA Ethylene ditetraacetic acid EMSA Electrophoretic mobility shift assay FOG1 Friend of GATA 1/ZFPM1 FRET Fluorescence/Förster resonance energy transfer Gata-1 GATA binding protein 1 (globin transcription factor 1) GCN4 General control protein GCN4 GFP Green fluorescent protein GSH Glutathione GST Glutathione-S-transferase HA Human influenza hemagglutinin HADDOCK High ambiguity driven protein-protein DOCKing HD Homeodomain HEK-293 Human embryonic kidney cells 293 HEPES 4-(2-hydroxylethyl)-1-piperazineethanesulfonic acid His-tag 6 × histidine tag HRP Horseradish peroxidase HRV-3C Human Rhinovirus 3C HSQC Heteronuclear single quantum correlation IDP Intrinsically disordered proteins IDR Intrinsically disordered regions IPTG Isopropyl β-D-thiogalactopyranoside ITC Isothermal titration calorimetry KA Association constant KD Dissociation constant kDa Kilodalton KO Knock-out LB Luria-Bertani broth LCCD Ldb1/CHIP conserved domain LCR Locus control region Ldb1 LIM domain binding protein 1 vi Ldb2 Lim domain binding protein 2 LDS Lithium dodecyl sulfate Lhx LIM homeobox protein LID LIM interaction domain LIM Lin1-Isl1-Mec3 (protein domain) LIM-HD LIM-homeodomain Lmo LIM only protein MALLS Multi angle laser light scattering MBP Maltose-binding protein MCS Multiple cloning site MEL Murine erythroleukemia MES 2-(N-morpholino)ethanesulfonic acid MQW MilliQ® water MW Molecular weight MWCO Molecular weight cut off N Stoichiometric ratio NF/N-finger Amino-terminal zinc finger Ni-NTA Nickel nitrile-triacetic acid NLS Nuclear localisation domain NMR Nuclear magnetic resonance spectroscopy OD600 Optical density at 600 nm PBD Protein data bank PBS Phosphate-buffered saline PCR Polymerase chain reaction PEG Polyethylene glycol PEI Polyethylenimine PMSF Phenylmethanesulfonyl fluoride PTM Post-translational modifications RING Really interesting new gene RIPA Radioimmunoprecipitation assay RLIM RING finger LIM-domain interacting protein vii RLIMBD RLIM basic domain RNA Ribonucleic acid S. pombe Schizosacchraomyces pombe SA Self-association SAXS Small-angle C-ray scattering SD Synthetic dextrose SDS Sodium dodecyl sulphate SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis SEC Size exclusion chromatography SOC Super Optimal Broth SSBP Single stranded binding protein SSDP Single stranded DNA-binding protein TAE Tris/acetate/EDTA Tal1 T-cell acute lymphocytic leukemia protein 1 T-ALL T-cell acute lymphoblastic leukaemia` TBS Tris-buffered saline TCEP Tris(2-carboxyethyl)phosphine TE Tris/EDTA TF Transcription factor Tm Melting temperature Tris Tris(2-carboxymethyl)aminomethane USF-1 U-shaped finger 1 UV Ultraviolet WT Wild-type X-α-gal 5-bromo-4-chloro-3-indolyl-α-D-galactopyranoside YPD Yeast peptone dextrose viii Table of Contents Statement of originaliy ............................................................................................................. i Acknowledgments .................................................................................................................... ii Abstract ................................................................................................................................... iii Abbreviations .......................................................................................................................... iv Table of Contents ................................................................................................................. viii List of Figures .......................................................................................................................... xi List of Tables .........................................................................................................................
Recommended publications
  • Characterization of a Pediatric T-Cell Acute Lymphoblastic Leukemia Patient with Simultaneous LYL1 and LMO2 Rearrangements

    Characterization of a Pediatric T-Cell Acute Lymphoblastic Leukemia Patient with Simultaneous LYL1 and LMO2 Rearrangements

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository Articles and Brief Reports Acute Lymphoblastic Leukemia Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements Irene Homminga, 1 Maartje J. Vuerhard, 1 Anton W. Langerak, 2 Jessica Buijs-Gladdines, 1 Rob Pieters, 1 and Jules P.P. Meijerink 1 1Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children’s Hospital, Rotterdam; and 2Department of Immunology, Erasmus MC, Rotterdam, The Netherlands ABSTRACT Translocation of the LYL1 oncogene are rare in T-cell acute consistently clustered along with cases having TAL1 or lymphoblastic leukemia, whereas the homologous TAL1 LMO2 rearrangements. Therefore, LYL1 -rearranged cases are gene is rearranged in approximately 20% of patients. not necessarily associated with immature T-cell develop - Previous gene-expression studies have identified an imma - ment, despite high LYL1 levels, but elicit a TALLMO expres - ture T-cell acute lymphoblastic leukemia subgroup with high sion signature. LYL1 expression in the absence of chromosomal aberrations. Molecular characterization of a t(7;19)(q34;p13) in a pediatric Key words: T-ALL, pediatric, LYL1, LMO2, rearrangements. T-cell acute lymphoblastic leukemia patient led to the identi - fication of a translocation between the TRB@ and LYL1 loci. Citation: Homminga I, Vuerhard MJ, Langerak AW, Buijs- Similar to incidental T-cell acute lymphoblastic leukemia Gladdines J, Pieters R, and Meijerink JPP. Characterization of a cases with synergistic, double translocations affecting pediatric T-cell acute lymphoblastic leukemia patient with simul - TAL1/2 and LMO1/2 oncogenes, this LYL1 -translocated taneous LYL1 and LMO2 rearrangements.
  • DNA·RNA Triple Helix Formation Can Function As a Cis-Acting Regulatory

    DNA·RNA Triple Helix Formation Can Function As a Cis-Acting Regulatory

    DNA·RNA triple helix formation can function as a cis-acting regulatory mechanism at the human β-globin locus Zhuo Zhoua, Keith E. Gilesa,b,c, and Gary Felsenfelda,1 aLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; bUniversity of Alabama at Birmingham Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL 35294; and cDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294 Contributed by Gary Felsenfeld, February 4, 2019 (sent for review January 4, 2019; reviewed by James Douglas Engel and Sergei M. Mirkin) We have identified regulatory mechanisms in which an RNA tran- of the criteria necessary to establish the presence of a triplex script forms a DNA duplex·RNA triple helix with a gene or one of its structure, we first describe and characterize triplex formation at regulatory elements, suggesting potential auto-regulatory mecha- the FAU gene in human erythroid K562 cells. FAU encodes a nisms in vivo. We describe an interaction at the human β-globin protein that is a fusion containing fubi, a ubiquitin-like protein, locus, in which an RNA segment embedded in the second intron of and ribosomal protein S30. Although fubi function is unknown, the β-globin gene forms a DNA·RNA triplex with the HS2 sequence posttranslational processing produces S30, a component of the within the β-globin locus control region, a major regulator of glo- 40S ribosome. We used this system to refine methods necessary bin expression. We show in human K562 cells that the triplex is to detect triplex formation and to distinguish it from R-loop stable in vivo.
  • Ldb1 Is Essential for Development of Nkx2.1 Lineage Derived Gabaergic and Cholinergic Neurons in the Telencephalon

    Ldb1 Is Essential for Development of Nkx2.1 Lineage Derived Gabaergic and Cholinergic Neurons in the Telencephalon

    Developmental Biology 385 (2014) 94–106 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/locate/developmentalbiology Ldb1 is essential for development of Nkx2.1 lineage derived GABAergic and cholinergic neurons in the telencephalon Yangu Zhao a,n,1, Pierre Flandin b,2, Daniel Vogt b, Alexander Blood a, Edit Hermesz a,3, Heiner Westphal a, John L. R. Rubenstein b,nn a Program on Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892, USA b Department of Psychiatry and the Nina Ireland Laboratory of Developmental Neurobiology, University of California San Francisco, San Francisco, CA 94143, USA article info abstract Article history: The progenitor zones of the embryonic mouse ventral telencephalon give rise to GABAergic and cholinergic Received 1 June 2013 neurons. We have shown previously that two LIM-homeodomain (LIM-HD) transcription factors, Lhx6 and Received in revised form Lhx8, that are downstream of Nkx2.1, are critical for the development of telencephalic GABAergic and 8 October 2013 cholinergic neurons. Here we investigate the role of Ldb1, a nuclear protein that binds directly to all LIM-HD Accepted 9 October 2013 factors, in the development of these ventral telencephalon derived neurons. We show that Ldb1 is expressed Available online 21 October 2013 in the Nkx2.1 cell lineage during embryonic development and in mature neurons. Conditional deletion of Ldb1 Keywords: causes defects in the expression of a series of genes in the ventral telencephalon and severe impairment in the Differentiation tangential migration of cortical interneurons from the ventral telencephalon.
  • Open Dogan Phdthesis Final.Pdf

    Open Dogan Phdthesis Final.Pdf

    The Pennsylvania State University The Graduate School Eberly College of Science ELUCIDATING BIOLOGICAL FUNCTION OF GENOMIC DNA WITH ROBUST SIGNALS OF BIOCHEMICAL ACTIVITY: INTEGRATIVE GENOME-WIDE STUDIES OF ENHANCERS A Dissertation in Biochemistry, Microbiology and Molecular Biology by Nergiz Dogan © 2014 Nergiz Dogan Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy August 2014 ii The dissertation of Nergiz Dogan was reviewed and approved* by the following: Ross C. Hardison T. Ming Chu Professor of Biochemistry and Molecular Biology Dissertation Advisor Chair of Committee David S. Gilmour Professor of Molecular and Cell Biology Anton Nekrutenko Professor of Biochemistry and Molecular Biology Robert F. Paulson Professor of Veterinary and Biomedical Sciences Philip Reno Assistant Professor of Antropology Scott B. Selleck Professor and Head of the Department of Biochemistry and Molecular Biology *Signatures are on file in the Graduate School iii ABSTRACT Genome-wide measurements of epigenetic features such as histone modifications, occupancy by transcription factors and coactivators provide the opportunity to understand more globally how genes are regulated. While much effort is being put into integrating the marks from various combinations of features, the contribution of each feature to accuracy of enhancer prediction is not known. We began with predictions of 4,915 candidate erythroid enhancers based on genomic occupancy by TAL1, a key hematopoietic transcription factor that is strongly associated with gene induction in erythroid cells. Seventy of these DNA segments occupied by TAL1 (TAL1 OSs) were tested by transient transfections of cultured hematopoietic cells, and 56% of these were active as enhancers. Sixty-six TAL1 OSs were evaluated in transgenic mouse embryos, and 65% of these were active enhancers in various tissues.
  • The Role of Noncoding Mutations in Blood Cancers Sunniyat Rahman and Marc R

    The Role of Noncoding Mutations in Blood Cancers Sunniyat Rahman and Marc R

    © 2019. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2019) 12, dmm041988. doi:10.1242/dmm.041988 REVIEW The role of noncoding mutations in blood cancers Sunniyat Rahman and Marc R. Mansour* ABSTRACT survival in adult acute myeloid leukaemia (AML) and ALL are The search for oncogenic mutations in haematological malignancies still less than 50%, with significant treatment challenges including has largely focused on coding sequence variants. These variants treatment-resistant disease, clonal heterogeneity of the underlying have been critical in understanding these complex cancers in greater disease, treatment-associated toxicities and poor tolerance for detail, ultimately leading to better disease monitoring, subtyping and intensive treatment regimens, particularly in older patients with prognostication. In contrast, the search for oncogenic variants in the comorbidities (Kansagra et al., 2018). Because of this, there is a noncoding genome has proven to be challenging given the vastness significant impetus to discover new genetic aberrations, including of the search space, the intrinsic difficulty in assessing the impact of driver mutations (see Box 1 for a glossary of terms), that may variants that do not code for functional proteins, and our still primitive provide insight into the mechanisms of malignant haematopoiesis, understanding of the function harboured by large parts of the as well as offering novel therapeutic opportunities. noncoding genome. Recent studies have broken ground on this Detailed genetic characterisation of haematological malignancies quest, identifying somatically acquired and recurrent mutations in the has already identified alterations that are now being used for better noncoding genome that activate the expression of proto-oncogenes. diagnosis, prognostication, subtype identification and to inform In this Review, we explore some of the best-characterised examples therapeutic decisions (Taylor et al., 2017).
  • LMO T-Cell Translocation Oncogenes Typify Genes Activated by Chromosomal Translocations That Alter Transcription and Developmental Processes

    LMO T-Cell Translocation Oncogenes Typify Genes Activated by Chromosomal Translocations That Alter Transcription and Developmental Processes

    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes Terence H. Rabbitts1 Medical Research Council (MRC) Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Cambridge CB2 2QH, UK The cytogenetic analysis of tumors, particularly those of ment (immunoglobulin or T-cell receptor) occurs and oc- hematopoietic origin, has revealed that reciprocal chro- casionally mediates chromosomal translocation. This mosomal translocations are recurring features of these type of translocation causes oncogene activation result- tumors. Further from the initial recognition of the trans- ing from the new chromosomal environment of the re- location t(9;22) (Nowell and Hungerford 1960; Rowley arranged gene. In general, this means inappropriate gene 1973), it has become clear that particular chromosomal expression. The second, and probably the most common translocations are found consistently in specific tumor outcome of chromosomal translocations, is gene fusion subtypes. A principle example of this is the translocation in which exons from a gene on each of the involved chro- t(8;14)(q24;q32.1) invariably found in the human B cell mosomes are linked after the chromosomal transloca- tumor Burkitt’s lymphoma (Manolov and Manolov 1972; tion, resulting in a fusion mRNA and protein. This type Zech et al. 1976). The link with the immunoglobulin of event is found in many cases of hematopoietic tumors H-chain locus on chromosome 14, band q32.1 (Croce et and in the sarcomas. al. 1979; Hobart et al.
  • A Previously Unrecognized Promoter of LMO2 Forms Part of A

    A Previously Unrecognized Promoter of LMO2 Forms Part of A

    Oncogene (2010) 29, 5796–5808 & 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 www.nature.com/onc ORIGINAL ARTICLE A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients SH Oram1, JAI Thoms2, C Pridans1, ME Janes2, SJ Kinston1, S Anand1, J-R Landry3, RB Lock4, P-S Jayaraman5, BJ Huntly1, JE Pimanda2 and B Go¨ttgens1 1Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK; 2Lowy Cancer Research Centre and The Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia; 3Institute for Research in Immunology and Cancer, Universite´ de Montre´al, Montre´al, Quebec, Canada; 4Children’s Cancer Institute Australia, University of New South Wales, Sydney, New South Wales, Australia and 5Birmingham University Stem Cell Centre, University of Birmingham, Edgbaston, Birmingham, UK The T-cell oncogene Lim-only 2 (LMO2) critically Introduction influences both normal and malignant haematopoiesis. LMO2 is not normally expressed in T cells, yet ectopic Lim-only 2 (LMO2), also known as TTG2 or RBTN2, expression is seen in the majority of T-acute lympho- was originally reported as a T-cell oncogene where it blastic leukaemia (T-ALL) patients with specific translo- was recurrently rearranged by chromosomal transloca- cations involving LMO2 in only a subset of these patients. tion in T-cell malignancies (Boehm et al., 1991; Royer- Ectopic lmo2 expression in thymocytes of transgenic mice Pokora et al., 1991). LMO2 encodes a 156 amino-acid causes T-ALL, and retroviral vector integration into the transcriptional co-factor containing two LIM domain LMO2 locus was implicated in the development of clonal zinc-fingers (Kadrmas and Beckerle, 2004) that do not T-cell disease in patients undergoing gene therapy.
  • Letters to the Editor

    Letters to the Editor

    LETTERS TO THE EDITOR The significant upregulation of Gata1 and EpoR mRNA Mice over-expressing human erythropoietin expression in hEPO over-expressing tg6 mice was con - indicate that erythropoietin enhances expression firmed by analyzing the spleen as a major source of of its receptor via up-regulated Gata1 and Tal1 hematopoiesis (Figure 2A and B). To further dissect the complexity of changes in the transcriptional network, the analysis of Myb mRNA expression served as marker for The development of medullary hematopoiesis is char - adult definitive erythroblasts, 10 showing significantly acterized by a specific expression profile of hematopoiet - ic transcription factors, including GATA transcription fac - tors. At mid-gestation, when hematopoiesis is newly A GATA 1 2 established in the bone marrow of human fetuses, initial - wt ly high GATA2 expression becomes subsequently down- regulated, while GATA1 expression increases in parallel. 1 1.5 Both transcription factors bind to overlapping sets of tg6 hematopoietic downstream target genes, often at distinct 1 sites, to regulate the balance between proliferation and differentiation. Chromatin occupancy by GATA1 and 0.5 GATA2 can change in the course of hematopoietic differ - entiation, leading to the so-called GATA switch. 2 Thus, a 0 n d7 d21 d49 i spatio-temporal regulation of GATA1 or GATA2 activities t c is required within lineage-specific differentiation. During a - erythroid differentiation GATA1 expression peaks at the b B GATA 2 3 o level of colony-forming units (CFU-E), where erythro - t 2 e poietin (Epo) exerts most specifically its effects, but v i t blocks terminal maturation if constitutively over- a 1.5 l 4 e expressed.
  • Rahman Et Al 2017 Somatically Acquired Activation of LMO2 in T-ALL

    Rahman Et Al 2017 Somatically Acquired Activation of LMO2 in T-ALL

    Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Rahman, Sunniyat, Michael Magnussen, Theresa E. León, Nadine Farah, Zhaodong Li, Brian J. Abraham, Krisztina Z. Alapi, et al. “Activation of the LMO2 Oncogene through a Somatically Acquired Neomorphic Promoter in T-Cell Acute Lymphoblastic Leukemia.” Blood 129, no. 24 (March 7, 2017): 3221–3226. As Published https://doi.org/10.1182/blood-2016-09-742148 Publisher American Society of Hematology Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/117283 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ 1 Activation of the LMO2 oncogene through a somatically acquired 2 neomorphic promoter in T-Cell Acute Lymphoblastic Leukemia 3 4 Sunniyat Rahman1, Michael Magnussen1, Theresa E. León1, Nadine Farah1, Zhaodong Li2, 5 Brian J Abraham3, Krisztina Z. Alapi1, Rachel J. Mitchell1, Tom Naughton1, Adele K. 6 Fielding1, Arnold Pizzey1, Sophia Bustraan1, Christopher Allen1, Teodora Popa , Karin Pike- 7 Overzet5, Laura Garcia-Perez5, Rosemary E. Gale1, David C. Linch1, Frank J.T. Staal5, 8 Richard A. Young3,4, A. Thomas Look2,6, Marc R. Mansour1 9 10 1. University College London Cancer Institute, Department of Haematology, 72 Huntley 11 Street, London. WC1E 6DD. United Kingdom. 12 2. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical 13 School, Boston, MA 02215 14 3. Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 15 02142 16 4.
  • The Human Na+/H+ Exchanger 1 Is a Membrane Scaffold Protein for Extracellular Signal-Regulated Kinase 2

    The Human Na+/H+ Exchanger 1 Is a Membrane Scaffold Protein for Extracellular Signal-Regulated Kinase 2

    The human Na+/H+ exchanger 1 is a membrane scaffold protein for extracellular signal-regulated kinase 2 Hendus-Altenburger, Ruth; Pedraz Cuesta, Elena; Olesen, Christina Wilkens; Papaleo, Elena; Schnell, Jeff Alexander; Hopper, Jonathan T. S.; Robinson, Carol V.; Pedersen, Stine Helene Falsig; Kragelund, Birthe Brandt Published in: BMC Biology DOI: 10.1186/s12915-016-0252-7 Publication date: 2016 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Hendus-Altenburger, R., Pedraz Cuesta, E., Olesen, C. W., Papaleo, E., Schnell,+ J.+ A., Hopper, J. T. S., Robinson, C. V., Pedersen, S. H. F., & Kragelund, B. B. (2016). The human Na /H exchanger 1 is a membrane scaffold protein for extracellular signal-regulated kinase 2. BMC Biology, 14, [31]. https://doi.org/10.1186/s12915-016-0252-7 Download date: 23. sep.. 2021 Hendus-Altenburger et al. BMC Biology (2016) 14:31 DOI 10.1186/s12915-016-0252-7 RESEARCH ARTICLE Open Access The human Na+/H+ exchanger 1 is a membrane scaffold protein for extracellular signal-regulated kinase 2 Ruth Hendus-Altenburger1,2, Elena Pedraz-Cuesta1, Christina W. Olesen1, Elena Papaleo2, Jeff A. Schnell2, Jonathan T. S. Hopper3, Carol V. Robinson3, Stine F. Pedersen1* and Birthe B. Kragelund2* Abstract Background: Extracellular signal-regulated kinase 2 (ERK2) is an S/T kinase with more than 200 known substrates, and with critical roles in regulation of cell growth and differentiation and currently no membrane proteins have been linked to ERK2 scaffolding. Methods and results: Here, we identify the human Na+/H+ exchanger 1 (hNHE1) as a membrane scaffold protein for ERK2 and show direct hNHE1-ERK1/2 interaction in cellular contexts.
  • Role of LDB1 in the Transition from Chromatin Looping to Transcription Activation

    Role of LDB1 in the Transition from Chromatin Looping to Transcription Activation

    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press Role of LDB1 in the transition from chromatin looping to transcription activation Ivan Krivega, Ryan K. Dale, and Ann Dean1 Laboratory of Cellular and Developmental Biology, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA Many questions remain about how close association of genes and distant enhancers occurs and how this is linked to transcription activation. In erythroid cells, lim domain binding 1 (LDB1) protein is recruited to the b-globin locus via LMO2 and is required for looping of the b-globin locus control region (LCR) to the active b-globin promoter. We show that the LDB1 dimerization domain (DD) is necessary and, when fused to LMO2, sufficient to completely restore LCR–promoter looping and transcription in LDB1-depleted cells. The looping function of the DD is unique and irreplaceable by heterologous DDs. Dissection of the DD revealed distinct functional properties of conserved subdomains. Notably, a conserved helical region (DD4/5) is dispensable for LDB1 dimerization and chromatin looping but essential for transcriptional activation. DD4/5 is required for the recruitment of the coregulators FOG1 and the nucleosome remodeling and deacetylating (NuRD) complex. Lack of DD4/5 alters histone acetylation and RNA polymerase II recruitment and results in failure of the locus to migrate to the nuclear interior, as normally occurs during erythroid maturation. These results uncouple enhancer–promoter looping from nuclear migration and transcription activation and reveal new roles for LDB1 in these processes.
  • Behaviour of Intrinsically Disordered Proteins in Protein–Protein Complexes with an Emphasis on Fuzziness

    Behaviour of Intrinsically Disordered Proteins in Protein–Protein Complexes with an Emphasis on Fuzziness

    Cell. Mol. Life Sci. (2017) 74:3175–3183 DOI 10.1007/s00018-017-2560-7 Cellular and Molecular Life Sciences MULTI-AUTHOR REVIEW Behaviour of intrinsically disordered proteins in protein–protein complexes with an emphasis on fuzziness 1 1 1 Johan G. Olsen • Kaare Teilum • Birthe B. Kragelund Received: 18 May 2017 / Accepted: 1 June 2017 / Published online: 8 June 2017 Ó The Author(s) 2017. This article is an open access publication Abstract Intrinsically disordered proteins (IDPs) do not, Introduction by themselves, fold into a compact globular structure. They are extremely dynamic and flexible, and are typically Signalling and regulation are essential to all living cells involved in signalling and transduction of information and are based on intermolecular interactions, most of which through binding to other macromolecules. The reason for are mediated by proteins. A substantial fraction of proteins their existence may lie in their malleability, which enables include large regions of disorder without clearly defined them to bind several different partners with high speci- three-dimensional structure. Such intrinsically disordered ficity. In addition, their interactions with other proteins (IDPs) are not only very abundant—30–40% of all macromolecules can be regulated by a variable amount of proteins in the human proteome are disordered or contain chemically diverse post-translational modifications. Four intrinsically disordered regions (IDRs) [1, 2]—they also kinetically and energetically different types of complexes constitute significant parts of membrane proteins [3, 4] and between an IDP and another macromolecule are reviewed: occupy pivotal positions in cellular regulation on all levels (1) simple two-state binding involving a single binding site, [5].